PGA
AGN

Portland Global Advisors’s Allergan Inc AGN Stock Holding History

Portland Global Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,676
Closed -$1.63M – 118
2014
Q4 		$1.63M Sell
7,676
-1,230
-14% -$245K 0.84% 31
2014
Q3 		$1.59M Sell
8,906
-275
-3% -$45.7K 0.82% 34
2014
Q2 		$1.55M Sell
9,181
-310
-3% -$48.3K 0.78% 35
2014
Q1 		$1.18M Sell
9,491
-849
-8% -$103K 0.69% 38
2013
Q4 		$1.15M Buy
10,340
+195
+2% +$18.6K 0.71% 40
2013
Q3 		$918K Buy
10,145
+115
+1% +$10.3K 0.62% 43
2013
Q2 		$845K Buy
+10,030
New +$1.04M 0.6% 45

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Portland Global Advisors's AGN Position: Q1 2015 in Review

Portland Global Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 7,676 shares — an estimated $1.63M sold.

Portland Global Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.63M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Portland Global Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Portland Global Advisors sold 7,676 Allergan Inc shares in Q1 2015, an estimated $1.63M.
  • Portland Global Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Portland Global Advisors's Allergan Inc position peaked at $1.63M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Portland Global Advisors's 13F filing for Q1 2015, filed 24 Apr 2015.